Stay updated on SB2 vs Remicade in RA Clinical Trial.
Sign up to get notified when there's something new on the SB2 vs Remicade in RA Clinical Trial. page.

Latest updates to the SB2 vs Remicade in RA Clinical Trial. page
- Check5 days agoChange DetectedAdded related topics (Rheumatoid arthritis, MedlinePlus Genetics) and updated the page revision to v3.5.0, replacing the previous v3.4.3.SummaryDifference0.2%

- Check12 days agoChange DetectedRevision tag updated from v3.4.2 to v3.4.3 in the page footer.SummaryDifference0.1%

- Check19 days agoChange DetectedRemoved from the page: Rheumatoid arthritis and related topics such as MedlinePlus Genetics. This reduces the disease context and linked resources available to users viewing the study record.SummaryDifference0.2%

- Check27 days agoNo Change Detected
- Check41 days agoChange DetectedRevision: v3.4.2 has been added to the page. The prior funding-lapse notice and Revision: v3.4.1 have been removed.SummaryDifference0.4%

- Check48 days agoChange DetectedA new global notice about government funding affecting site updates and the NIH Clinical Center open status has been added. The revision label changed from v3.4.0 to v3.4.1.SummaryDifference0.5%

- Check55 days agoChange DetectedThe page now displays a glossary and updates capitalization for labels such as Last Update Submitted that Met QC Criteria and No FEAR Act Data. The footer shows Revision: v3.4.0 instead of the previous version v3.3.4.SummaryDifference0.2%

Stay in the know with updates to SB2 vs Remicade in RA Clinical Trial.
Enter your email address, and we'll notify you when there's something new on the SB2 vs Remicade in RA Clinical Trial. page.